L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function

Cardiovascular Research

Volumn 30, Issue 2, 1995, Pages 200-204

  Amrani, M ^a   Chester, A H ^a   Jayakumar, J ^a   Schyns, C J ^a   Yacoub, M H ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Cardioplegia; Endothelium; L Arginine; Myocardial ischemia; Nitric oxide; Rat heart; Reperfusion

Indexed keywords

ARGININE; LYSINE; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOTHELIUM; HEART FUNCTION; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMAL; ARGININE; COMPARATIVE STUDY; CORONARY CIRCULATION; HEART; HEART ARREST, INDUCED; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 0029146401     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1016/S0008-6363(95)00021-6     Document Type: Article

References (21)

1. Kloner RA, Ganotte CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496–1508.
2. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor from the canine vascular endothelium. J Physiol (Lond). 1985;364:45–56.
3. Jennings RB, Reimer KA, Steenbergen C. Myocardial ischemia revisited: the osmolar load, membrane damage and reperfusion. J Mol Cell Cardiol 1986;18:769–780.
4. Amrani M, Shirvani R, Allen NJ, Ledingham S, Yacoub MH. Enhancement of low coronary reflow improves postischemic myocardial function. J Thorac Cardiovasc Surg 1992;104:1375–1382.
5. Hanaki Y, Sugiyama S, Ajioka M, Kondo T, Fukushimo A, Azawa T. Acceleration of recovery of mitochondrial function after coronary reperfusion by various coronary dilating drugs in canine hearts. J Cardiovasc Pharmacol 1989;13;336–341.
6. Reibel DK, Rovetto MJ. Myocardial adenosine salvage rates and restoration of ATP following ischemia. Am J Physiol 1979;6:H347–H352.
7. Quillen JE, Selke FW, Brooks LA, Harrison DG. Ischemia–reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 1990;2:586–594.
8. Pelc LR, Garancis JC, Gross GH, Warltier DC. Alteration of endothelium-dependent distribution of myocardial blood flow after coronary occlusion and reperfusion. Circulation 1990;81:1928–1937.
9. Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during myocardial ischemia. Circulation 1976;54:193–202.
10. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from l-rginine. Nature 1988;333:664–666.
11. Bogle RG, Baydoun AR, Pearson JD, Moneada, Mann GE. l-Arginine transport is increased in macrophages generating nitric oxide. Biochem J 1992;15(284):15–18.
12. Amrani M, O’Shea J, Allen NJ, et al. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol 1992;456:681–687.
13. Palmer RMJ, Moneada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Commun 1989;158:348–352.
14. Warren JB, Pons F, Brady AJB. Nitric oxide biology: implications for cardiovascular therapeutics. Cardiovasc Res 1994;28:25–30.
15. Petros A, Lamb G, Leone A, Moneada S, Bennett D, Vallance P. Effects of nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994;28:34–39.
16. Weyrich AS, Xin-liang MA, Lefer AM. The role of l-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279–288.
17. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. Role of l-arginine–nitric oxide pathway in hypertension. J Hypertens 1993;11:639–645.
18. Cooke JF, Andon NA, Girerd XJ, Hirash AT, Kreager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991;83:1057–1062.
19. Nakanishi K, Vinten-Johansen J, Lefer DJ, et al. Intracoronary l-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992;263:H1650–H1658.
20. Rubanyi GM, Vanhoutte PM. Superoxide anion and hypoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822–H827.31.
21. Tsao PS, Lefer AM. Time course and mechanisms of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol 1990;259:H1660–H1666.